Repros Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
Repros Announces Pricing Of $3.0 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, May 18, 2017 3:12 PM EDT
Repros Therapeutics Inc., announced today that it has entered into an underwriting agreement to sell in a public offering 2,744,125 shares of the Company’s common stock.
In this article: RPRX
Read
Premarket Biotech Digest – CBMG Inks New Deal, IPCI Sued, SYRS Gets FDA Nod
Article By: KKD Healthcare Analytics
Tuesday, April 11, 2017 9:34 AM EDT
Geron Corporation stock picked up on the news that the company has agreed to a settlement related to a consolidated class-action securities lawsuit. The company stock jumped over 19 percent in its previous trading session.
In this article: TXMD, GERN, IPCI, RPRX, GBLX, OMED, CBMG, SYRS
Read
FDA Keeping A Partial "Hold" On Repros Therapeutics’ Proellex
Article By: Lorimer Wilson
Monday, April 10, 2017 7:59 PM EDT
The FDA plans to maintain a partial clinical hold on Repros Therapeutics' Proellex so regulators can take extra time in consulting with agency experts on the liver effects spotted in the clinic.
In this article: RPRX
Read
5 Top Biotech Performers Of 2016
Article By: Zacks Investment Research
Saturday, July 2, 2016 6:39 PM EDT
2016 has been a busy year for the Biotech industry. Let’s take a look 5 of the strongest year-to-date (YTD) performers. Here are five Biotech stocks that have experienced a YTD price change of >20% and sit at a Zacks Rank #2 (Buy) or better.
In this article: RPRX, OPXA, ANIP, XBIT, ARGS
Read
E Repros Therapeutics Surges 175% On Positive Phase 2 Results
Article By: Terry Chrisomalis
Friday, April 15, 2016 8:36 AM EDT
Microcap biopharma RPRX stock surpasses $3 mark for the first time since October 2015.
In this article: RPRX
Read

PARTNER HEADLINES

Latest Tweets for $RPRX

No tweets yet!